Asher Bio

Active

We build better immunotherapies

What it does

Asher Bio is a biotechnology company developing precisely targeted immunotherapies for cancer and other diseases. Our cis-targeting platform aims to enable selective activation of specific immune cell types, addressing the inherent limitations of otherwise pleiotropic immunotherapies that act on multiple cell types. Our approach has the potential to precisely direct different immune mediators against a range of target immune cell-types and create best-in-class immunotherapies in cancer, autoimmune and infectious diseases. Asher Bio is backed by Third Rock Ventures and is located in South San Francisco.

Next to it in Healthcare and bio · precision immunotherapy platform

  • Endpoint HealthY Combinator W19

    Precision-first therapies

  • PhrazeTechstars TS 2019

    Phraze - Transforming the Healthcare

  • Kernal BiologicsY Combinator S20

    Kernal is creating mRNA 2.0 therapies that work in specific cells

  • BioptamersSOSV SOSV IndieBio RebelBio 07

    Personalized precision therapies

  • Helix NanotechnologiesY Combinator W17

    Next-generation mRNA platform to solve cancer, COVID and climate.

  • Silene BiotechTechstars TS 2017

    silenebiotech.com

  • Organicin ScientificTechstars TS 2022

    Organicin Scientific | Bacteriocins to Prevent Disease

  • RyboDynSOSV SOSV IndieBio SF 15

    Unlocking the dark proteome for high-resolution immunotherapies